A Study to Evaluate the Metabolism, Excretion, and Mass Balance of [¹⁴C]Enlicitide Chloride ([¹⁴C]MK-0616) in Healthy Participants (MK-0616-016)
Clinical trial NCT06658626 · COMPLETED
Trial details
- NCT number
- NCT06658626
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-10
- Primary completion
- 2023-08-02
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.